TALK-2 Activators
TALK-2 Activators enhance the activity of the TALK-2 protein through a diverse array of biochemical mechanisms, each distinctively influencing cellular signaling pathways to augment the protein's function. Forskolin, by directly stimulating adenylyl cyclase, leads to a rise in intracellular cAMP levels, thereby activating protein kinase A (PKA), which is poised to phosphorylate and enhance the activity of TALK-2. This cascade of events is similarly triggered by Isoproterenol, a beta-adrenergic agonist, and maintained by compounds like 1-Ethyl-2-benzimidazolinone, Vinpocetine, Minaprine, and Zardaverine, all of which inhibit phosphodiesterase, preventing cAMP breakdown and ensuring prolonged PKA activation and potential phosphorylation of TALK-2. The cAMP analog Dibutyryl cAMP further solidifies this activation route by directly stimulating PKA, circumventing upstream signaling requirements.
Concurrently, the modulation of ionic currents also plays a pivotal role in TALK-2 activation. Bay K8644, an L-type calcium channel agonist, increases intracellular calcium, which could indirectly activate TALK-2 by affecting calcium-dependent regulatory mechanisms. Similarly, NS1619, by opening large-conductance Ca2+-activated K+ channels, could induce a hyperpolarizing shift in the membrane potential, favoring TALK-2 channel activity. Retigabine operates by opening KCNQ potassium channels, further contributing to hyperpolarization and thus providing a conducive electrochemical landscape for TALK-2 function. Pregnenolone sulfate, through neurosteroid action, may alter TALK-2's conformation or protein-protein interactions, leading to enhanced channel activity. Flufenamic acid, although primarily classified as an NSAID, has been recognized for its ability to activate specific potassium channels, suggesting a putative route for TALK-2 activation.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin directly stimulates adenylyl cyclase, increasing intracellular cAMP levels. Elevated cAMP activates protein kinase A (PKA), which can phosphorylate various targets, potentially including ion channels like TALK-2, leading to its activation. | ||||||
1-EBIO | 10045-45-1 | sc-201695 sc-201695A | 10 mg 50 mg | $87.00 $325.00 | 1 | |
1-Ethyl-2-benzimidazolinone is a phosphodiesterase (PDE) inhibitor, which prevents cAMP breakdown, thereby sustaining PKA activation. Persistent PKA activity can enhance TALK-2 channel function through phosphorylation. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Isoproterenol is a beta-adrenergic agonist that activates adenylyl cyclase through G protein-coupled receptor signaling, raising cAMP levels and activating PKA. PKA can then enhance TALK-2 activity by phosphorylation. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
Dibutyryl cAMP is a cell-permeable cAMP analog that directly activates PKA. Activated PKA may increase TALK-2 activity by phosphorylating the channel or associated regulatory proteins. | ||||||
Vinpocetine | 42971-09-5 | sc-201204 sc-201204A sc-201204B | 20 mg 100 mg 15 g | $55.00 $214.00 $2400.00 | 4 | |
Vinpocetine is a PDE inhibitor that elevates cAMP levels by preventing its hydrolysis, thus indirectly enhancing TALK-2 activity through sustained PKA signaling. | ||||||
(±)-Bay K 8644 | 71145-03-4 | sc-203324 sc-203324A sc-203324B | 1 mg 5 mg 50 mg | $84.00 $196.00 $817.00 | ||
Bay K8644 is an L-type calcium channel agonist that increases intracellular calcium levels, which can modulate various calcium-dependent proteins, potentially leading to the activation of TALK-2 channels indirectly. | ||||||
Pregnenolone sulfate sodium salt | 1852-38-6 | sc-301609 | 50 mg | $99.00 | 2 | |
Pregnenolone sulfate is a neurosteroid that modulates various ion channels, including potassium channels. It may enhance TALK-2 activity by modulating the channel's conformation or interaction with other proteins. | ||||||
Minaprine dihydrochloride | 25905-77-5 | sc-253049 | 1 g | $65.00 | ||
Minaprine is a PDE inhibitor that increases intracellular cAMP, thereby activating PKA. PKA can then phosphorylate TALK-2 or its associated proteins, enhancing the channel's activity. | ||||||
Flufenamic acid | 530-78-9 | sc-205699 sc-205699A sc-205699B sc-205699C | 10 g 50 g 100 g 250 g | $27.00 $79.00 $154.00 $309.00 | 1 | |
Flufenamic acid is a nonsteroidal anti-inflammatory drug (NSAID) that has been shown to activate certain types of potassium channels. It may indirectly enhance TALK-2 activity by modulating similar sites or pathways. | ||||||
Zardaverine | 101975-10-4 | sc-201208 sc-201208A | 5 mg 25 mg | $88.00 $379.00 | 1 | |
Zardaverine is a PDE3/4 inhibitor that raises cAMP levels, leading to activation of PKA. PKA activation can enhance TALK-2 activity through phosphorylation of the channel or regulatory proteins. | ||||||